Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.
about
The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population.Cardiovascular effects of fingolimod: A review article.Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis.
P2860
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Advances in the treatment of r ...... tical appraisal of fingolimod.
@ast
Advances in the treatment of r ...... tical appraisal of fingolimod.
@en
type
label
Advances in the treatment of r ...... tical appraisal of fingolimod.
@ast
Advances in the treatment of r ...... tical appraisal of fingolimod.
@en
prefLabel
Advances in the treatment of r ...... tical appraisal of fingolimod.
@ast
Advances in the treatment of r ...... tical appraisal of fingolimod.
@en
P2860
P356
P1476
Advances in the treatment of r ...... itical appraisal of fingolimod
@en
P2093
Carlo Pozzilli
Chiara Rosa Mancinelli
P2860
P356
10.2147/TCRM.S17426
P577
2013-03-03T00:00:00Z